ask="2.93"
ask_size="1000"
average_daily_volume="189537"
bid="2.72"
bid_size="200"
book_value="0.56"
change="-0.08"
change_from_200_day_moving_average="0.32"
change_from_50_day_moving_average="0.18"
change_from_52_week_high="-1.12"
change_From_52_week_low="0.69"
change_in_percent="-2.83%"
close="2.75"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.31"
ebitda="-5.76M"
eps_estimate_current_year="-0.34"
eps_estimate_next_quarter="-0.21"
eps_estimate_next_year="-0.91"
ex_dividend_date="N/A"
float_shares="16233000"
high="2.84"
high_52_weeks="3.87"
last_trade_date="1/30/2017"
last_trade_price="2.75"
last_trade_size="100"
last_trade_time="3:59pm"
low="2.72"
low_52_weeks="2.06"
market_capitalization="51.39M"
moving_average_200_day="2.43"
moving_average_50_day="2.57"
name="Brainstorm Cell Therapeutics In"
notes="N/A"
one_year_target_price="6.00"
open="2.80"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+13.17%"
percent_change_from_50_day_moving_average="+6.88%"
percent_change_from_52_week_high="-28.94%"
percent_change_from_52_week_low="+33.50%"
previous_close="2.83"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="5.03"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="18687000"
short_ratio="1.38"
stock_exchange="NCM"
symbol="BCLI"
volume="40866"
weeks_range_52="2.06 - 3.87"
